93 related articles for article (PubMed ID: 19739573)
1. Fencing Fisher: alternative methods for patenting expressed sequence tags.
Noonan D
Health Matrix Clevel; 2008; 18(2):441-61. PubMed ID: 19739573
[No Abstract] [Full Text] [Related]
2. Patenting expressed sequence tags and single nucleotide polymorphisms.
Flattmann GJ; Kaplan JM
Nat Biotechnol; 2001 Aug; 19(8):777-9. PubMed ID: 11479574
[No Abstract] [Full Text] [Related]
3. Patenting expressed sequence tags and single nucleotide polymorphisms.
Flattmann GJ; Kaplan JM
Nat Biotechnol; 2001 Jul; 19(7):683-4. PubMed ID: 11433286
[No Abstract] [Full Text] [Related]
4. Intellectual property. Court tightens patent rules on gene tags.
Kintisch E
Science; 2005 Sep; 309(5742):1797-9. PubMed ID: 16166482
[No Abstract] [Full Text] [Related]
5. Analyzing the USPTO's revised utility guidelines. United States Patent and Trademark Office.
Kowalski TJ
Nat Biotechnol; 2000 Mar; 18(3):349-50. PubMed ID: 10700156
[No Abstract] [Full Text] [Related]
6. US court case to define EST patentability.
Lawrence S
Nat Biotechnol; 2005 May; 23(5):513. PubMed ID: 15877055
[No Abstract] [Full Text] [Related]
7. Intellectual property rights in genes and gene fragments: a registration solution for expressed sequence tags.
Holman MA; Munzer SR
Iowa Law Rev; 2000 Mar; 85(3):735-848. PubMed ID: 16523593
[No Abstract] [Full Text] [Related]
8. Reinventing the double helix: a novel and nonobvious reconceptualization of the biotechnology patent.
Demaine LJ; Fellmeth AX
Stanford Law Rev; 2002 Nov; 55(2):303-462. PubMed ID: 12494955
[No Abstract] [Full Text] [Related]
9. Patent on gene fragment sends researchers a mixed message...as Germany hesitates over Brussels directive.
Reichhardt T
Nature; 1998 Dec; 396(6711):499. PubMed ID: 9859973
[No Abstract] [Full Text] [Related]
10. Biotechnology. Lawsuit challenges legal basis for patenting human genes.
Marshall E
Science; 2009 May; 324(5930):1000-1. PubMed ID: 19460975
[No Abstract] [Full Text] [Related]
11. Patenting biotech beyond the central dogma.
Wu G
Nat Biotechnol; 2010 Mar; 28(3):230-3. PubMed ID: 20212482
[No Abstract] [Full Text] [Related]
12. The gene patenting controversy: a convergence of law, economic interests, and ethics.
Kevles DJ; Berkowitz A
Brooklyn Law Rev; 2001; 67(1):233-48. PubMed ID: 12645549
[No Abstract] [Full Text] [Related]
13. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.
Schrell A; Bauser H; Brunner H
Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818
[TBL] [Abstract][Full Text] [Related]
14. Of mice and men: patenting the oncomouse.
Knowles LP
Hastings Cent Rep; 2003; 33(2):6-7. PubMed ID: 12760110
[No Abstract] [Full Text] [Related]
15. Patentable subject matter, TRIPS and the European Biotechnology Directive: Australia and patenting human genes.
Palombi L
Univ N S W Law J; 2003; 26(3):782-92. PubMed ID: 16617532
[No Abstract] [Full Text] [Related]
16. Equivalents in biotechnology patents.
Auer HE
Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574
[No Abstract] [Full Text] [Related]
17. A benchside guide to patents and patenting.
Johnson E
Nat Biotechnol; 1996 Mar; 14(3):288-91. PubMed ID: 9630888
[No Abstract] [Full Text] [Related]
18. Patenting DNA: just when you thought it was safe.
Chahine KG
Nat Biotechnol; 1997 Jun; 15(6):586-8. PubMed ID: 9181584
[No Abstract] [Full Text] [Related]
19. Patenting Dr. Venter's genetic findings: is the National Institutes of Health creating hurdles or clearing the path for biotechnology's voyage in the twenty-first century?
Riley PJ
J Contemp Health Law Policy; 1994; 10():309-26. PubMed ID: 10134812
[No Abstract] [Full Text] [Related]
20. Patenting ESTs: is it worth it?
Nat Genet; 1999 Feb; 21(2):145-6. PubMed ID: 9988257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
